SCHEDULE 13G

CUSIP No.

38942Q202

1

Names of Reporting Persons

Bering Partners II, L.P. ("Bering II")

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 663,246.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 663,246.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

663,246.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person: Note to row 5, 7 and 9: 663,246 shares, except that Bering Partners II GP, L.L.C., the general partner of Bering II ("Bering II GP"), and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Bering II and Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer"), the managing members of Bering II GP, may be deemed to have shared power to vote these shares. Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024. With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651. Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

SCHEDULE 13G

CUSIP No.

38942Q202

1

Names of Reporting Persons

Bering Partners II GP, L.L.C. ("Bering II GP")

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 663,246.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 663,246.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

663,246.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: Note to row 5, 7 and 9: 663,246 shares, of which all are directly owned by Bering II. Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares. Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares. Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024. With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651. Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

SCHEDULE 13G

CUSIP No.

38942Q202

1

Names of Reporting Persons

Evgeny Zaytsev ("Zaytsev")

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 663,246.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 663,246.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

663,246.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Note to row 6, 8 and 9: 663,246 shares, of which all are directly owned by Bering II. Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares and Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares. Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024. With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651. Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

SCHEDULE 13G

CUSIP No.

38942Q202

1

Names of Reporting Persons

Philip Sawyer ("Sawyer")

2

Check the appropriate box if a member of a Group (see instructions)

(a)

(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 663,246.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 663,246.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

663,246.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

Checkbox not checked

11

Percent of class represented by amount in row (9)

5.8 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: Note to row 6, 8 and 9: 663,246 shares, of which all are directly owned by Bering II. Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote these shares and Zaytsev and Sawyer, the managing members of Bering II GP, may be deemed to have shared power to vote these shares. Note to row 11: Includes (i) 663,246 shares of Common Stock held by Bering II and (ii) 130,651 shares of Common Stock issuable upon exercise of a pair of warrants to purchase shares of Common Stock (the "Warrants") held by Bering II, and based on 13,481,917 shares of the Issuer's Common Stock outstanding as of November 6, 2024 as set forth in the Issuer's quarterly report on Form 10-Q for the quarter ended September 30, 2024. With respect to the Warrants, Bering II GP originally had 261,302 shares in connection with the Warrants but as of December 31, 2024, one of the warrants expired which reduced the number of shares in connection with exercise under the remaining warrant to 130,651. Pursuant to Rule 13d-3(d)(1)(i)(D), the percentage in Row 11 is calculated using the outstanding shares of Class A Common Stock only (assuming conversion of the 130,651 of shares attributable to the remaining exercisable warrants held by Bering II GP as of January 23, 2024).

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

CalciMedica, Inc.

(b)

Address of issuer's principal executive offices:

505 Coast Boulevard South, Suite 307, La Jolla, CA 92037

Item 2.

(a)

Name of person filing:

This Statement is filed by Bering Partners II, L.P. ("Bering II"), Bering Partners II GP, L.L.C., a Delaware limited liability company ("Bering II GP"), Evgeny Zaytsev ("Zaytsev") and Philip Sawyer ("Sawyer"). The foregoing entities and individuals are collectively referred to as the "Reporting Persons." Bering II GP, the general partner of Bering II, may be deemed to have sole power to vote and sole power to dispose of shares of the issuer directly owned by Bering II. Zaytsev and Sawyer are managing members of Bering II GP and may be deemed to have shared power to vote and shared power to dispose of shares of the issuer directly owned by Bering II.

(b)

Address or principal business office or, if none, residence:

Bering Capital 601 California Street, Suite 620 San Francisco, CA 94108

(c)

Citizenship:

Bering II is a Delaware limited partnership. Bering II GP is a Delaware limited liability company. Zaytsev and Sawyer are United States citizens.

(d)

Title of class of securities:

Common Stock, par value $0.0001 per share

(e)

CUSIP No.:

38942Q202

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

See Row 9 of cover page for each Reporting Person

(b)

Percent of class:

See Row 11 of cover page for each Reporting Person

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

See Row 5 of cover page for each Reporting Person

(ii) Shared power to vote or to direct the vote:

See Row 6 of cover page for each Reporting Person

(iii) Sole power to dispose or to direct the disposition of:

See Row 7 of cover page for each Reporting Person

(iv) Shared power to dispose or to direct the disposition of:

See Row 8 of cover page for each Reporting Person

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.

Under certain circumstances set forth in the limited partnership agreement of Bering II, and the limited liability company agreement of Bering II GP, the general and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a partner or member, as the case may be.

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Bering Partners II, L.P. ("Bering II")

Signature:	/s/ Evgeny Zaytsev
Name/Title:	Managing Member of the General Partner
Date:	10/29/2025

Bering Partners II GP, L.L.C. ("Bering II GP")

Signature:	/s/ Evgeny Zaytsev
Name/Title:	Managing Member
Date:	10/29/2025

Evgeny Zaytsev ("Zaytsev")

Signature:	/s/ Evgeny Zaytsev
Name/Title:	Evgeny Zaytsev
Date:	10/29/2025

Philip Sawyer ("Sawyer")

Signature:	/s/ Philip Sawyer
Name/Title:	Philip Sawyer
Date:	10/29/2025